Compounded GIP + GLP-1 Program · Contains Tirzepatide

Tirzepatide. Two pathways. One clinician who stays with you.

You’ll talk to Kris or Dr. Lula

A weekly injection that works on both the GIP and GLP-1 pathways. Kris or Dr. Lula review your history and labs, decide with you whether it fits, and adjust the dose with you month by month. Compounded by a state-licensed 503A pharmacy. Telehealth in Michigan, Florida, Alabama, Mississippi, Georgia, Colorado, Pennsylvania, Ohio, Arkansas and Arizona. From $265/mo. Free consultation.

  • LegitScript certified
  • Board-certified providers
  • Royal Oak clinic + telehealth
Kris Cutaj, MSPAS, PA-C, FAACM, in NuHealth scrubs at the Royal Oak clinic

Your clinicians

Kris Cutaj, MSPAS, PA-C, FAACM

Kris Cutaj, MSPAS, PA-C, FAACM

Board-certified physician assistant

Kris and Dr. Lula decide with you whether tirzepatide fits, then adjust the dose month by month.

Working with Dr. Lula

Compounded Tirzepatide

from $265/mo

Medication, monthly check-ins, labs and dose titration.

Dr. Erald Lula, MD, MPH — Medical Director, NuHealth Medical Wellness

Medically reviewed by

Dr. Erald Lula, MD, MPH

Triple Board-Certified: Internal Medicine, Obesity Medicine, Lifestyle Medicine

Last reviewed: Bio

One monthly price. Two pathways working at once.

Every tirzepatide plan combines the compounded dual-incretin medication, care from Kris or Dr. Lula, and the labs and dose changes that keep a GIP + GLP-1 protocol on track over time.

Compounded tirzepatide vial — a dual GIP/GLP-1 receptor agonist prepared by a licensed pharmacy for NuHealth's supervised program.

The dual-incretin medication

Compounded tirzepatide

A synthetic peptide that activates both GIP and GLP-1 receptors, prepared by a state-licensed 503A pharmacy on a per-prescription basis. Shipped discreetly after clinician authorization.

from $265/moMedication, monthly check-ins and labs

Your clinicians

Kris and Dr. Lula

Licensed in your state. Free 20-minute consultation reviewing your full medical history. Monthly check-ins and direct messaging.

Your labs and dose

Labs and dose changes with Kris or Dr. Lula

Baseline labs before any prescription. Gradual titration over the first 16 to 20 weeks across both pathways. Quarterly labs and response tracking with your clinician.

“Pricing posted up front: Compounded Tirzepatide from $265 / month. Your clinician determines whether a personalized compounded program is clinically appropriate for you at the consultation.”

What is compounded tirzepatide? Two receptors, one weekly dose.

Tirzepatide is a synthetic peptide that activates two incretin receptors at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Semaglutide is a single-pathway GLP-1 agonist; tirzepatide is dual.

A “compounded” medication is one prepared by a state-licensed compounding pharmacy on a prescription-by-prescription basis. NuHealth’s compounded tirzepatide is prepared by a 503A compounding pharmacy when your NuHealth clinician determines that a personalized formulation fits your clinical situation. This per-patient framework is what allows ongoing compounding of tirzepatide under current FDA rules.

Compounded tirzepatide is not FDA-approved as a finished drug product, and is not Mounjaro® or Zepbound® (the FDA-approved finished drugs by Eli Lilly). Your NuHealth clinician will explain how this affects your treatment plan during your consultation.

Macro detail of a compounded tirzepatide vial — the crimp seal and pharmacy label.

How it works in the body

  1. GIP pathway

    Activates the GIP receptor — glucose-dependent insulinotropic polypeptide.

  2. GLP-1 pathway

    Activates the GLP-1 receptor — the same target a single-incretin GLP-1 hits alone.

  3. Energy + appetite regulation

    Together the two pathways influence satiety, glucose handling, and energy.

How Kris and Dr. Lula run your tirzepatide program. Three steps, on your timeline.

  1. Kris Cutaj, MSPAS, PA-C, FAACM, in NuHealth scrubs at the Royal Oak clinic.

    Free 20-minute consultation

    Kris or Dr. Lula reviews your medical history, weight history, prior GLP-1 response (if any), and any medications or conditions that may affect candidacy for a dual-incretin program. If you are not a candidate for compounded tirzepatide, they talk through alternatives. The consultation itself is free.

  2. A compounded tirzepatide vial beside a lab requisition form, baseline labs before Kris or Dr. Lula confirms candidacy.

    Labs, read by Kris or Dr. Lula

    Kris or Dr. Lula orders baseline labs (typically HbA1c, lipid panel, kidney function, and a metabolic panel), reviews your results, and confirms whether a personalized compounded tirzepatide program is appropriate for you. If they authorize treatment, your prescription is sent to our 503A compounding pharmacy partner.

  3. A quiet morning still-life; the steady ongoing-care rhythm of a NuHealth program.

    Labs and dose changes with Kris or Dr. Lula

    Monthly check-ins with Kris or Dr. Lula. Quarterly labs to track how your body responds across both pathways. Your clinician adjusts dose, slows titration, or recommends a different protocol entirely if side effects are limiting. You can message your clinician directly between appointments.

Throughout, your treatment plan is the responsibility of your NuHealth clinician, informed by your full medical history, labs, and response across both incretin pathways.

Candidacy

Who may be a candidate for tirzepatide? Honest about the biology.

Compounded tirzepatide may be appropriate for adults whose clinician determines that a dual-incretin medication fits their clinical situation. Here is how candidacy is generally framed before your consultation.

Clinician-assessed at your consultation

May be appropriate

  • Adults with a BMI of 27 or higher and at least one weight-related condition (high blood pressure, prediabetes, type 2 diabetes, sleep apnea, cardiovascular disease, or similar)
  • Adults with a BMI of 30 or higher
  • Adults who had a partial response or plateaued on a single-pathway GLP-1 protocol and want to discuss a dual-receptor option
  • Adults whose metabolic profile or clinician judgment suggests benefit from activating both GIP and GLP-1 pathways

Generally not appropriate

  • Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of severe pancreatitis, severe gastroparesis, or other significant GI disease
  • Active pregnancy, breastfeeding, or planning pregnancy within the next 2 months
  • Known hypersensitivity to tirzepatide or related ingredients
Kris or Dr. Lula makes the final call after reviewing your history, medications and labs.

What patients describe. Often, two pathways at once.

Many patients describe a quieting of food noise plus steadier mid-day energy. The GLP-1 pathway is the one a single-incretin agonist hits; the GIP pathway also influences insulin secretion, so glucose handling often feels more stable between meals. Individual response varies; your clinician tracks your specific timeline at every check-in.

  1. Weeks 1-2

    Starting dose · 2.5 mg weekly

    Your clinician starts you low, at 2.5 mg weekly, so your body adjusts to dual-receptor onboarding. Many patients describe early appetite changes; mild nausea is the most common side effect and usually resolves.

  2. Week 4

    First titration · often 5 mg

    A check-in decides the first step up. If the starting dose is well-tolerated, your clinician may increase it (commonly to 5 mg).

  3. Week 12

    7.5-10 mg range · full rhythm

    By three months, many patients have settled into a stable dose with their clinician. At each check-in your clinician reviews progress, side effects, and labs.

  4. Week 24

    Outcomes review · 12.5-15 mg band

    Around six months your clinician does a full review. Some patients move to a lower-dose maintenance phase; others continue at a 12.5 or 15 mg maintenance band.

The pattern above is what patients commonly describe. It is not a guarantee of outcome. Your clinician tailors the plan to your specific metabolic profile, labs, and goals.

The program at a glance

Two pathways, one supervised plan.

Tirzepatide acts on two incretin pathways. Your clinician starts you at a low dose and titrates gradually, reviewing how you respond at every check-in. Compounded tirzepatide is prepared per-patient by a state-licensed 503A pharmacy. Individual results vary — your plan is built around your biology, under medical supervision.

Pharmacy

503A

State-licensed compounding

Reply time

<24h

Typical reply on the patient portal

States

10

MI · FL · AL · MS · GA · CO · PA · OH · AR · AZ

Google rating

5.0★

From verified patients

Compounded tirzepatide vial on warm linen — prepared by a state-licensed 503A pharmacy for NuHealth's supervised program.

The medication

Compounded tirzepatide

Prepared to your clinician’s prescription by a state-licensed 503A compounding pharmacy.

See if you’re a candidate

Free 20-minute consultation · Your clinician decides candidacy

Pricing

One monthly price. Two pathways included.

The compounded tirzepatide program covers the medication, clinician check-ins, labs, and dose titration across both GIP and GLP-1 pathways. Transparent pricing, no insurance middleman.

  • Free consultation

    Free. No charge for the visit, whatever the outcome.

  • No hidden fees

    The monthly price covers medication, clinician care, and labs.

  • Cancel anytime

    Programs continue only when you and your clinician agree.

Dual-mechanism program

Compounded Tirzepatide

GIP + GLP-1 dual receptor agonist, prepared per prescription.

from $265/mo

3-month starter program

  • Compounded tirzepatide from a 503A pharmacy partner
  • Free 20-minute consultation
  • Monthly check-ins with your clinician
  • Quarterly labs and review
  • Direct messaging with your clinician
  • Discreet shipping
Start Free Assessment

A free 20-minute consultation with your clinician comes before any prescription.

CareCredit · Financing partner

Spread the program over months.

GLP-1 programs run $125–$265 a month. With CareCredit, split the medication, labs, and follow-through over a longer schedule. Prequalification has no impact on your credit score.

Check your prequalification

CareCredit is a financing product from Synchrony Bank. NuHealth Medical Wellness does not own, operate, or set the terms of CareCredit. Approval, rates, and terms are determined by Synchrony at application.

Kris Cutaj, PA-C, at the reception desk of the NuHealth clinic on Woodward Avenue in Royal Oak, under the lit NuHealth logo.

Royal Oak clinic. Telehealth wherever you are.

In-person consults for patients in metro Detroit. Telehealth in Michigan, Florida, Alabama, Mississippi, Georgia, Colorado, Pennsylvania, Ohio, Arkansas, and Arizona. The medication ships to your door; when you need to walk in for labs, an in-person visit, or a dose discussion, our clinic is on Woodward, between Birmingham and Berkley.

NuHealth Medical Wellness30301 Woodward Ave, Suite 240
Royal Oak, MI 48073

Frequently asked questions. Clear answers.

Three topics, in plain language. If you do not see your question, the free consultation is the place to ask it.

What is compounded tirzepatide?

Tirzepatide is a synthetic peptide that activates two incretin receptors at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). A compounded preparation is one prepared by a state-licensed compounding pharmacy on a per-prescription basis. NuHealth’s compounded tirzepatide is prepared by our 503A pharmacy partner when your clinician determines a personalized formulation is appropriate for your situation. It is not FDA-approved as a finished drug product.

How is tirzepatide different from semaglutide?

Semaglutide activates the GLP-1 receptor only. Tirzepatide activates both the GIP and the GLP-1 receptors. Some patients respond better to one approach versus the other; the right choice depends on your medical history, prior treatment response, and lab profile. Your NuHealth clinician helps determine which medication fits your specific situation.

How long does it take to notice changes?

Many patients describe noticing appetite changes within the first 1–2 weeks. Measurable changes typically appear later. Your clinician tracks your specific timeline at every check-in. Individual response varies.

What does NuHealth’s tirzepatide program cost?

$265/month. The monthly price includes the medication (when prescribed), clinician check-ins, lab orders and your clinician’s review of the results, dose titration, and direct messaging with your clinician. Lab fees are billed separately by the lab. The 20-minute consultation with your clinician is free. NuHealth does not bill insurance.

Is compounded tirzepatide the same as Mounjaro or Zepbound?

No. NuHealth’s compounded tirzepatide is not Mounjaro® or Zepbound®. Those are FDA-approved finished drug products manufactured and tested by Eli Lilly (Mounjaro for type 2 diabetes, Zepbound for chronic weight management). NuHealth’s compounded tirzepatide is prepared by a state-licensed 503A compounding pharmacy on a per-prescription basis and is not FDA-approved as a finished drug product. Clinical-trial outcomes from FDA-approved branded products do not transfer to compounded preparations. Your clinician will explain the distinction during your consultation.

What if I miss a dose?

If you remember within 4 days of your scheduled dose, take it as soon as you remember and continue your normal weekly schedule. If more than 4 days have passed, skip the missed dose and continue with your next scheduled one. Don’t double up. If you have questions about dosing, message your clinician.

Do I have to inject myself?

Yes — tirzepatide is a subcutaneous injection, given once a week. The needles are very fine (similar to insulin pens). Your clinician walks you through the technique at your first appointment.

What happens if I stop?

Many patients regain some weight when they stop. Your clinician will work with you on a tapering plan if you decide to discontinue. Some patients move to a lower-dose maintenance schedule with their clinician; others step down over months as lifestyle changes take hold. The plan is individualized.

Lifestyle photograph. Not the patient quoted.
Rxin program

From a patient

“After a year of partial progress on a single-pathway GLP-1, switching changed the whole conversation about my biology.”

Tom L.

Tirzepatide Program

Step one

Labs reviewed first

Then

Titrate monthly check-ins

Individual results vary

Begin your free assessment

The next step

Talk to Kris or Dr. Lula. See if tirzepatide fits you.

NuHealth provides telehealth care to adults in Michigan, Florida, Alabama, Mississippi, Georgia, Colorado, Pennsylvania, Ohio, Arkansas, and Arizona, with in-person consultations available at our Royal Oak, MI clinic. Start with a free 20-minute consultation. Your clinician decides whether it’s appropriate, based on your medical history and labs.

  • LegitScript Certified
  • No credit card to start
  • Free consultation